---
figid: PMC9066102__ijbsv18p2833g004
pmcid: PMC9066102
image_filename: ijbsv18p2833g004.jpg
figure_link: /pmc/articles/PMC9066102/figure/F4/
number: Figure 4
figure_title: ''
caption: 'ZDHHC22 reduces AKT pathway activation. A. Gene set enrichment analysis
  (GSEA) based on microarray datasets GSE65194 and GSE21653. B. The western blotting
  assay was used to detect the expression of AKT signaling pathway-related molecules.
  C. Predicted cysteine residues on mTOR and DEPTOR susceptible to S-palmitoylation
  using palmitoylation site prediction tool CSS-Plam 4.0. ZDC22:ZDHHC22, ZDC22-mut:
  ZDHHC22-(C111A) mutation.'
article_title: ZDHHC22-mediated mTOR palmitoylation restrains breast cancer growth
  and endocrine therapy resistance.
citation: Jiefeng Huang, et al. Int J Biol Sci. 2022;18(7):2833-2850.
year: '2022'

doi: 10.7150/ijbs.70544
journal_title: International Journal of Biological Sciences
journal_nlm_ta: Int J Biol Sci
publisher_name: Ivyspring International Publisher

keywords:
- Breast cancer
- ZDHHC22
- Palmitoylation
- mTOR
- Endocrine therapy resistance

---
